B1 Other refereed article (e.g., editorial, letter, comment) in a scientific journal

CHA2DS2-VASc or a non-sex score (CHA2DS2-VA) for stroke risk prediction in atrial fibrillation: contemporary insights and clinical implications




AuthorsLip, Gregory Y.H.; Teppo, Konsta; Nielsen, Peter Brönnum

PublisherOxford University Press

Publication year2024

JournalEuropean Heart Journal

Article numberehae540

Volume45

Issue36

First page 3718

Last page3720

ISSN0195-668X

eISSN1522-9645

DOIhttps://doi.org/10.1093/eurheartj/ehae540(external)

Web address https://doi.org/10.1093/eurheartj/ehae540(external)



Funding information in the publication
K.T. Research Grants: The Finnish Foundation for Cardiovascular Research, Aarne and Aili Turunen Foundation. P.B.N. Consultant fees from Boehringer Ingelheim, grants and consultant fees from Daiichi-Sankoy, grants from BMS/Pfizer, and grants and consultant fees from Bayer outside the submitted work. G.Y.H.L. Consultant and speaker for BMS/Pfizer, Boehringer Ingelheim, Daiichi-Sankyo, Anthos. No fees are received personally. He is a National Institute for Health and Care Research (NIHR) Senior Investigator and co-principal investigator of the AFFIRMO project on multimorbidity in AF, which has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement number 899871.


Last updated on 2025-06-03 at 14:57